42 reports

  • Risk Factors and Comorbidities for Type 1 Diabetes
  • 3.5.1 Diagnosed Prevalent Cases of Type 1 Diabetes

ua=## (Accessed: ## April 2019).

  • Type 1 Diabetes
  • Canada
  • United States
  • World
  • Forecast

Type ## Diabetes Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Chronic Disease
  • Type 1 Diabetes
  • APAC
  • World
  • Demand

Diabetes Type ## Market and Forecast Analysis to 2025 CONTENTS ## FORECAST: TYPE ## DIABETES (Published on ## June 2017) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## MARKET DEFINITION AND METHODOLOGY ## LATEST ANALYST OPINION ## APIDRA (INSULIN GLULISINE) ##

  • Type 1 Diabetes
  • European Union
  • Japan
  • United States
  • Demand
  • 4.2.3 Type 1 Diabetes Market and Forecast
  • GLOBAL - TYPE 1 DIABETES DIAGNOSTICS MARKET (MILLION US$), 2011 - 2018

In United Kingdom, an estimated of ## in every ##-## people under the age of ## have Type ## diabetes.

  • Type 1 Diabetes
  • World
  • Market Size
  • bioMerieux S.A.
  • Roche Group

Global Type ## Diabetes Epidemiology and Patient Flow Analysis - 2017 ##.

  • Chronic Disease
  • Type 1 Diabetes
  • United States
  • World
  • Forecast

Type ## Diabetes (T##D) Market Size, Forecast And Trend Analysis, 2014 - 2024 Chapter ##.

  • Insulin
  • Therapy
  • Type 1 Diabetes
  • United States
  • Forecast
  • TOP-LINE PREVALENCE FOR TYPE 1 DIABETES MELLITUS
  • Prevalence of Type 1 Diabetes Mellitus, females (000s)

Prevalence of Type ## Diabetes Mellitus, males (##s) Table ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • Type 1 Diabetes

Europe Type ## Diabetes Epidemiology and Patient Flow Analysis - 2017 ##.

  • Type 1 Diabetes
  • Europe
  • France
  • Germany
  • Forecast

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Market Shares
  • Market Size
  • TYPE 1 DIABETES DRUGS MARKET IN EMEA 2015-2020 ($ BILLIONS)
  • SEGMENTATION OF TYPE 1 DIABETES DRUGS MARKET BY DRUG CLASS

Phase II Type ## diabetes Type ## Diabetes ANTI-IL ## T##D (NN##) TEPLIZUMAB (MGA##) PROCHYMAL MacroGenics Company Stage of development Indication OI##GT (NN1953) Novo Nordisk ULTRA-RAPID INSULIN Eli Lilly PF-## BHV## HIP-##B NN1956 Pfizer BHV Pharma CureDm Novo Nordisk P

  • Diabetes
  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Type 1 Diabetes
  • TYPE 1 DIABETES WITH HYPOGLYCEMIA

THE COMPANY CLAIMS THAT DIABECELL IS EXPECTED TO BE ONE OF THE NOVEL THERAPEUTIC OPTIONS FOR REFRACTORY TYPE ## DIABETES. ##. ##. ##. ##.

  • Hospital
  • Type 1 Diabetes
  • United States
  • Erytech Pharma SA
  • Neurotech Pharmaceuticals, Inc.

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Market Shares
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Japan
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • United States
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • United Kingdom
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Italy
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Germany
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • France
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Spain
  • Market Size

Drug analysis: Farxiga

8770 10000 7800

Drug analysis: Farxiga PRODUCT PROFILES Farxiga : Diabetes type ## Farxiga : Diabetes type ## LIST OF FIGURES Figure ##: Farxiga for type ## diabetes – SWOT analysis Figure ##: Datamonitor Healthcare drug assessment of Farxiga Figure ##: Datamonitor Healthcare drug assessment scorecard

  • Diabetes
  • Type 1 Diabetes
  • European Union
  • Japan
  • United States
  • North America Insulin Pumps Market, By Value
  • L: EUROPE REGIONAL MARKERS: HISTORIC AND FORECAST

Insulin Pumps Outlook Type I Diabetes: Type I diabetes is an autoimmune disease that destroys the insulin producing beta cells in the pancreas of the human body.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation

Insulin Glargine in Patients with Type ## Diabetes ## Jun ##, 2018: Xeris Pharmaceuticals Announces Positive Phase ## Clinical Trial Data on Its Investigational Ready-to-Use Glucagon Rescue Pen ## Jun ##, 2018: Adding Liraglutide to Insulin Regimen for People with Type ## Diabetes Improved Gly

  • Chronic Disease
  • Clinical Trial
  • Therapy
  • Type 1 Diabetes
  • World
  • TYPE 1 DIABETES (JUVENILE DIABETES)
  • VACCINE FOR TYPE 1 DIABETES - DRUG PROFILE

Similarly, the Universities portfolio in Phase II, Phase I, Phase ##, Preclinical and Discovery stages comprises ##, ##, ##, ## and ## molecules, respectively.

  • Chronic Disease
  • Pathology
  • Therapy
  • Type 1 Diabetes
  • Product Initiative

The report focuses on drugs and therapies being evaluated for Type ## Diabetes (Juvenile Diabetes) treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Chronic Disease
  • Clinical Trial
  • Pathology
  • Type 1 Diabetes

2019 Type ## Diabetes Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Type 1 Diabetes
  • APAC

Type ## Diabetes Pipeline Highlights – 2017 ##.

  • Chronic Disease
  • Type 1 Diabetes
  • United States
  • Product Initiative
  • 03/29/2018: EMA to Review Sotagliflozin as Potential Treatment for type 1 diabetes
  • Mar 26, 2018: Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults with Type 1 Diabetes

" There are more than ## million adults with type ## diabetes in the United States alone, and the majority of these are not at their A##C goal of ## percent.

  • Pharmaceutical
  • Therapy
  • Type 1 Diabetes
  • United States
  • Lexicon Pharmaceuticals, Inc.
  • BIOARTIFICIAL PANCREAS - TYPE 1 DIABETES - PRODUCT STATUS
  • BIOARTIFICIAL PANCREAS - TYPE 1 DIABETES - PRODUCT DESCRIPTION

According to the International Diabetes Federation, there were more than one million children with type ## diabetes in 2017.

  • Clinical Trial
  • Diabetes Monitoring
  • Type 1 Diabetes
  • United States
  • Medtronic, Inc.
  • 05/22/2017: JDRF AND VIACYTE ANNOUNCE SUPPORT FOR DEVELOPMENT OF PEC-DIRECT CELL REPLACEMENT THERAPY FOR TYPE 1 DIABETES

Beyond Type ## seeks to make a better life for people living with type ## diabetes.

  • Healthcare
  • Therapy
  • Type 1 Diabetes
  • United States
  • ViaCyte, Inc.
  • 01/05/2017: ADOCIA LAUNCHES NEW MULTI-HORMONAL COMBINATION PROJECT FOR TREATMENT OF TYPE 1 DIABETES

In type ## diabetes, ultimately, neither insulin nor amylin is secreted and GLP-## secretion is deficient.

  • Insulin
  • Type 1 Diabetes
  • United States
  • Company
  • Adocia